In this context, mast cells may take part in the pro-coagulative status typical of COVID-19 patients by releasing pro-angiogenic VEGF-A, histamine, and tumor necrosis factor-α, thus leading to endothelial activation in inflamed alveolar septa and subsequent fibrin formation through activation of both extrinsic and intrinsic coagulation pathways [88,89]. The gene discussed is VEGFA; the disease is COVID-19.